Nitric oxide production by equine articular cells in vitro.

The research article explores the ability of horse joint cells to produce nitric oxide, a potential mediator of joint damage, in response to two arthritis-causing molecules, lipopolysaccharide and interleukin-1 beta.

Introduction and Objectives

• The research study aimed to investigate the production of Nitric Oxide (NO) by cultured equine articular chondrocytes. NO has been identified as a potential mediator of articular cartilage damage and an inhibitor of cartilage matrix neosynthesis in several species.
• The investigation focused on the response to two arthritogenic (arthritis-causing) molecules, lipopolysaccharide (LPS) and interleukin-1 beta (IL-1 beta).

Methodology

• In the experiment, equine chondrocytes were cultured and treated with LPS and IL-1 beta. Their ability to synthesise nitrite, a NO metabolite, was measured and compared to synoviocytes stimulated with LPS.
• The researchers also examined the influence of Nitric Oxide Synthase (NOS) inhibitors on nitrite production by the chondrocytes and synoviocytes.

Results

• The researchers found that synoviocytes exhibited a low basal level of NO synthesis that was not significantly increased nor decreased by exposure to LPS. Basal NO synthesis by synoviocytes was not significantly reduced by competitive inhibitors of NOS.
• In contrast, chondrocytes treated with LPS or IL-1 beta synthesised nitrite in a dose-related manner.
• NOS inhibitors suppressed nitrite production to below the basal levels of unstimulated cells.

Conclusion

• The findings reveal that equine chondrocytes have the capacity to synthesise nitric oxide, especially in response to LPS and IL-1 beta.
• However, the exact roles of NO in horse cartilage metabolism remain unclear and warrant further study.